Today is Microsoft's March 2026 Patch Tuesday with security updates for 79 flaws, including 2 publicly disclosed zero-day ...

Anthropic launches the Anthropic Institute to study AI’s impact on jobs, governance, and security as the company warns rapid advances could reshape society.

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $3.85, moving -3.27% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.33%. On ...

Recursion Pharmaceuticals (RXRX) shares recently closed at US$3.98, with the stock showing a negative return over the past month and past 3 months, which may prompt investors to reassess its current ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

A fully autonomous AI agent has claimed the top of HackerOne’s bug bounty leaderboard – and this month it submitted a CVSS 9.8 remote code execution flaw to Microsoft via HackerOne that the company ...